Tauriga Sciences, Inc. Subsidiary Pilus Energy to Participate in 2015 World Environmental & Water Resources Congress

CINCINNATI, Ohio, May 15, 2015 /PRNewswire/ — Tauriga Sciences, Inc. (OTCQB:  TAUG) (“Tauriga” or the “Company”), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, is pleased to announce that its subsidiary Pilus Energy will be participating in the 2015 World Environmental & Water Resources Congress in Austin, TX May 17-21 at the JW Marriot (110 E. Second St. Austin, TX 78701). Pilus will be presenting at the Sunday poster session from 4:30 pm to midnight. The theme for this year is Floods, Droughts, and Ecosystems: Managing Our Resources Despite Growing Demands and Diminishing Funds.

Created in 1999, the Environmental & Water Resources Institute (EWRI) is the recognized leader within the American Society of Civil Engineers (ASCE) for the integration of technical expertise and public policy in the planning, design, construction, and operation of environmentally sound and sustainable infrastructure impacting air, land, and water resources.

Tauriga’s Chairman & CEO Dr. Stella Sung stated, “We are delighted to share Pilus’s innovative technology in this forum, because our ultimate goal is to commercialize and apply Pilus’s proprietary, enhanced bacterial strains to improve our ecosystem amid more scarce natural resources.  We are committed to both our consumer natural wellness business and our ‘wastewater to value’ subsidiary, as we see promise for both to improve lives and bring shareholder value. ”

In addition to Pilus’s ongoing commercial pilot study to demonstrate feasibility of applying Pilus’s synthetic biology platform to a large scale industrial sewage treatment plant, Tauriga Advisory Board Member and Pilus Energy Co-Founder, Professor Daniel Hassett has generated promising preliminary data using synthetic urine as carbon source for a Pilus bacterial strain.  When the proprietary Pilus bacteria metabolized and remediated urine, the resulting power density was approximately threefold the power of any electrogenic bioreactor using urine to date, suggesting a possible near term opportunity in generating electricity using portable toilets.

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology.  The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms.  Please visit the Company’s corporate website at www.tauriga.com and the Company’s e-commerce website at www.taurigastore.com.



This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.



Forward-Looking Statements: Except for statements of historical fact, this news release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.



Dr. Stella M. Sung
Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
San Diego: + 1-858-353-5749
Montreal: + 1-514-840-3697
Email: ssung@tauriga.com

No Comments

Sorry, the comment form is closed at this time.